Global burden of Clostridium difficile infections: a systematic review and meta-analysis

• Published in: Journal of global health 2019-06, Vol.9 (1), p.010407-010407
• Main Authors: Balsells, Evelyn, Shi, Ting, Leese, Callum, Lyell, Iona, Burrows, John, Wiuff, Camilla, Campbell, Harry, Kyaw, Moe H, Nair, Harish
• Format: Article
• Language: English
• Subjects: Antibiotics; Authorship; Clostridium Infections - epidemiology; Disease control; Epidemics; Epidemiology; Estimates; Global health; Global Health - statistics & numerical data; Health facilities; Health surveillance; Hospitalization; Hospitals; Humans; Incidence; Infections; Intensive care; Internal medicine; Laboratories; Meta-analysis; Morbidity; Mortality; Nursing homes; Population; Public health; Studies; Systematic review
• ISSN: 2047-2978; 2047-2986
• DOI: 10.7189/jogh.09.010407

is a leading cause of morbidity and mortality in several countries. However, there are limited evidence characterizing its role as a global public health problem. We conducted a systematic review to provide a comprehensive overview of infections (CDI) rates. Seven databases were searched (January 2016) to identify studies and surveillance reports published between 2005 and 2015 reporting CDI incidence rates. CDI incidence rates for health care facility-associated (HCF), hospital onset-health care facility-associated, medical or general intensive care unit (ICU), internal medicine (IM), long-term care facility (LTCF), and community-associated (CA) were extracted and standardized. Meta-analysis was conducted using a random effects model. 229 publications, with data from 41 countries, were included. The overall rate of HCF-CDI was 2.24 (95% confidence interval CI = 1.66-3.03) per 1000 admissions/y and 3.54 (95%CI = 3.19-3.92) per 10 000 patient-days/y. Estimated rates for CDI with onset in ICU or IM wards were 11.08 (95%CI = 7.19-17.08) and 10.80 (95%CI = 3.15-37.06) per 1000 admission/y, respectively. Rates for CA-CDI were lower: 0.55 (95%CI = 0.13-2.37) per 1000 admissions/y. CDI rates were generally higher in North America and among the elderly but similar rates were identified in other regions and age groups. Our review highlights the widespread burden of disease of , evidence gaps, and the need for sustainable surveillance of CDI in the health care setting and the community.